The extended tau haplotype and the age of onset of dementia in Down syndrome

Dementia and Geriatric Cognitive Disorders

Volumn 26, Issue 3, 2008, Pages 199-202

  Jones, Emma L ^a   Margallo Lana, Marisa ^b   Prasher, Vee P ^c,d   Ballard, Clive G ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Northgate Hospital   (United Kingdom)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^d South Birmingham Primary Care Trust   (United Kingdom)

Author keywords

Alzheimer's disease; Down syndrome; Early onset dementia; Tau haplotype

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DOWN SYNDROME; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; TAU GENE;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DOWN SYNDROME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TAU PROTEINS; YOUNG ADULT;

EID: 54249163592     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000152044     Document Type: Article

References (20)

1. Prasher VP, Krishnan VH: Mental disorders and adaptive behaviour in people with Down's syndrome. Br J Psychiatry 1993;162:848-850.
2. Mann DMA, Esiri MM: The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome, J Neurol Sci 1989;89:169-179.
3. Flament S, Delacourte A, Mann DMA: Phosphorylation of Tau proteins: a major event during the process of neurofibrillary degeneration. A comparative study between Alzheimer's disease and Down's syndrome. Brain Res 1990;516:15-19.
4. Murphy GM Jr, Eng LF, Ellis WG, Perry G, Meissner LC, Tinklenberg JR: Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease. Brain Res 1990;537:102-108.
5. Raghavan R, Khin-Nu C, Brown AG, Day KA, Tyrer SP, Ince PG, Perry EK, Perry RH: Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21). Neuroreport 1994;5:1393-1396.
6. Margallo-Lana ML, Moore PB, Kay DWK, Perry RH, Reid BE, Berney TP, Tyrer SP: Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology. J Intellect Disabil Res 2007;51:463-477.
7. Margallo-Lana M, Morris CM, Gibson AM, Tan AL, Kay DW, Tyrer SP, Moore BP, Ballard CG: Influence of the amyloid precursor protein locus on dementia in Down syndrome. Neurology 2004;62:1996-1998.
8. Bullido MJ, Aldudo J, Frank A, Coria F, Avila J, Valdivieso F: A polymorphism in the tau gene associated with risk for Alzheimer's disease. Neurosci Lett 2000;278:49-52.
9. Lilius L, Froelich Fabre S, Basun H, Forsell C, Axelman K, Mattila K, Andreadis A, Viitanen M, Winblad B, Fratiglioni L, Lannfelt L: Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's disease. Neurosci Lett 1999;277:29-32.
10. Prasher V, Farooq A, Holder R: The Adaptive Behaviour Dementia Questionnaire (ABDQ): screening questionnaire for dementia in Alzheimer's disease in adults with Down syndrome. Res Dev Disabil 2004;25:385-397.
11. World Health Organization: International Classification of Diseases, ed 10. Geneva, World Health Organization, 1992.
12. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, Hutton M: Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999;8:711-715.
13. Holland AJ, Hon J, Huppert FA, Stevens F, Watson P: Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome. Br J Psychiatry 1998;172:493-498.
14. Wilcock GK, Esiri MM: Plaques, tangles and dementia. A quantitative study. J Neurol Sci 1982;56:343-356.
15. Caffrey TM, Joachim C, Wade-Martins R: Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus. Neurobiol Aging 2007, E-pub ahead of print.
16. Caffrey TM, Joachim C, Parracchini S, Esiri MM, Wade-Martins R: Haplotype-specific expression of exon 10 at the human MAPT locus. Hum Mol Genet 2006;15:3529-3537.
17. LladóA, Ezquerra M, Gaig C, Sánchez-Valle R, Tolosa E, Molinuevoe JL: Brain tau expression and correlation with the H1/H1 tau genotype in frontotemporal lobar degeneration patients. J Neural Transm 2007;114:1585-1588.
18. Pittman AM, Myers AJ, Duckworth J, Bryden L, Hanson M, Abou-Sleiman P, Wood NW, Hardy J, Lees A, de Silva R: The structure of the tau haplotype in controls and in progressive supranuclear palsy. Hum Mol Genet 2004;13:1267-1274.
19. Kimura R, Kamino K, Yamamoto M, Nirupa A, Kida T, Kazui H, Hashimoto R, Tanaka T, Kudo T, Yamagata H, Tabara Y, Miki T, Akatsu H, Kosaka K, Funakoshi E, Nishitomi K, Sakaguchi G, Kato A, Hattori H, Uema T, Takeda M: The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between β-amyloid production and tau phosphorylation in Alzheimer disease. Hum Mol Genet 2007;16:15-23.
20. Cook CN, Hejna MJ, Magnusson DJ, Lee JM: Expression of calcipressin1, an inhibitor of the phosphatase calcineurin, is altered with aging and Alzheimer's disease. J Alzheimers Dis 2005;8:63-73.